Andrew Krivoshik, MD of Astellas @AstellasUS discusses the importance of the phase III PROSPER trial in the prostate cancer community presented at this year’s virtual ASCO.
Read here: https://meetinglibrary.asco.org/record/187453/abstract
Advertisement